betamethasone valerate

Preferred Label : betamethasone valerate;

MeSH definition : The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity.;

MeSH synonym : 17-valerate, betamethasone; flubenisolonvalerate; betamethasone 17 valerate; valerate, betamethasone; betamethasone 17-Valerate;

CISMeF synonym : 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate;

MeSH hyponym : betnovate;

MeSH CAS label : Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-;

MeSH Related Number : 2152-44-5 (Betamethasone valerate);

Registry Number MeSH : 2152-44-5;

Codes EINECS : 218-439-3;

Is substance : O;

UNII : 9IFA5XM7R2;

InChIKey : SNHRLVCMMWUAJD-SUYDQAKGSA-N;

Details

Origin ID

D001624;

UMLS CUI

C0750848;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate, betamethasone valerate [Substance BNPC]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
- glucocorticoids [MeSH Descriptor]
Record concept(s)
- betamethasone valerate [MeSH concept]
- betnovate [MeSH concept]
Related MeSH Supplementary Concept(s)
- betamethasone 17-valerate, clioquinol drug combination [MeSH Supplementary Concept]
- betamethasone 17-valerate, clioquinol, gentamicin, tolnaftate drug combination [MeSH Supplementary Concept]
- betamethasone 17-valerate, neomycin drug combination [MeSH Supplementary Concept]
- quadriderm [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Betamethasone valerate (product) [Inactive SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate, betamethasone valerate [Substance BNPC]
- Betamethasone Valerate [NCIt concept]
- Betamethasone valerate (product) [Inactive SNOMED CT concept]
- Betamethasone valerate (substance) [SNOMED CT concept]
- betamethasone valerate [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients